Get startedLog in
    Picture of Heidelberg Pharma AG logo

    HPHA — Heidelberg Pharma AG Cashflow Statement

    0.000.00%
    de flag iconLast trade - 00:00
    HealthcareAdventurousSmall CapMomentum Trap
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual cashflow statement for Heidelberg Pharma AG, fiscal year end - November 30th, EUR millions except per share, conversion factor applied.

    2020
    November 30th
    2021
    November 30th
    2022
    November 30th
    2023
    November 30th
    2024
    November 30th
    Period Length:12 M12 M12 M12 M12 M
    Source:ARSARSARSARSARS
    Standards:
    IFRS
    IFRS
    IFRS
    IFRS
    IFRS
    Status:FinalFinalFinalFinalFinal
    Net Income/Starting Line-18.4-26.1-19.7-20.3-19.4
    Depreciation
    Non-Cash Items0.7541.20.496-4.120.371
    Unusual Items
    Equity in Net Earnings/Losses
    Other Non-Cash Items
    Changes in Working Capital-1.01-2.489.59-10.1-11.4
    Change in Accounts Receivable
    Change in Inventories
    Change in Prepaid Expenses
    Change in Other Assets
    Change in Accounts Payable
    Change in Other Liabilities
    Other Operating Cash Flow
    Cash from Operating Activities-17.9-26.6-8.86-33.7-29.6
    Capital Expenditures-1.43-1.39-0.613-0.96-0.478
    Purchase of Fixed Assets
    Purchase / Acquisition of Intangibles
    Other Investing Cash Flow Items0.144-0.0130.0156.810.029
    Sale of Fixed Assets
    Sale/Maturity of Investment
    Purchase of Investments
    Other Investing Cash Flow
    Cash from Investing Activities-1.29-1.4-0.5985.85-0.449
    Financing Cash Flow Items-0.061-0.749-0.8180-1.58
    Other Financing Cash Flow
    Net Issuance / Retirement of Stock
    Net Issuance / Retirement of Debt
    Cash from Financing Activities14.329.284-10.116.1
    Foreign Exchange Effects
    Beginning Cash Balance
    Ending Cash Balance
    Net Change in Cash-4.91.1675.2-37.9-14